NCT00732420View on ClinicalTrials.gov

Open-label Study of Topotecan and Pazopanib in Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

September 24, 2008

Primary Completion Date

June 12, 2013

Study Completion Date

June 12, 2013

Conditions
Solid Tumours
Interventions
DRUG

topotecan

Topoisomerase I inhibition.

DRUG

pazopanib

Tyrosine kinase inhibitor

Trial Locations (3)

19104

GSK Investigational Site, Philadelphia

1066 CX

GSK Investigational Site, Amsterdam

3584 CX

GSK Investigational Site, Utrecht

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY